Carvolix SA (EPA:CVX)
France · Delayed Price · Currency is EUR 3.370
-0.080 (-2.32%)
Apr 2, 2026, 5:35 PM CET
Carvolix Revenue
In the year 2025, Carvolix had annual revenue of 900.00K EUR, down -83.18%. Carvolix had revenue of 323.00K in the half year ending December 31, 2025, a decrease of -49.05%.
Revenue
900.00K
Revenue Growth
-83.18%
P/S Ratio
221.83
Revenue / Employee
11.84K
Employees
68
Market Cap
199.65M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 900.00K | -4.45M | -83.18% |
| Dec 31, 2024 | 5.35M | 4.13M | 337.09% |
| Dec 31, 2023 | 1.22M | -115.00K | -8.59% |
| Dec 31, 2022 | 1.34M | -112.00K | -7.72% |
| Dec 31, 2021 | 1.45M | 627.00K | 76.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Guerbet | 798.67M |
| Eurobio Scientific Société anonyme | 162.47M |
| Biosynex | 97.95M |
| Diagnostic Medical Systems | 49.47M |
| Median Technologies | 23.38M |
| Novacyt | 22.69M |
| Implanet | 12.47M |
| Mauna Kea Technologies | 8.18M |